Huestis MA - Search Results

1

Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis.

Milman G, Schwope DM, Gorelick DA, Huestis MA. Milman G, et al. Among authors: huestis ma. Clin Chim Acta. 2012 Apr 11;413(7-8):765-70. doi: 10.1016/j.cca.2012.01.011. Epub 2012 Jan 20. Clin Chim Acta. 2012. PMID: 22285315 Free PMC article.

2

Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.

Huestis MA, Henningfield JE, Cone EJ. Huestis MA, et al. J Anal Toxicol. 1992 Sep-Oct;16(5):276-82. doi: 10.1093/jat/16.5.276. J Anal Toxicol. 1992. PMID: 1338215 Clinical Trial.

3

Lowering the federally mandated cannabinoid immunoassay cutoff increases true-positive results.

Huestis MA, Mitchell JM, Cone EJ. Huestis MA, et al. Clin Chem. 1994 May;40(5):729-33. Clin Chem. 1994. PMID: 8174244

4

Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.

Huestis MA, Mitchell JM, Cone EJ. Huestis MA, et al. J Anal Toxicol. 1996 Oct;20(6):441-52. doi: 10.1093/jat/20.6.441. J Anal Toxicol. 1996. PMID: 8889681 Clinical Trial.

5

Detection times of marijuana metabolites in urine by immunoassay and GC-MS.

Huestis MA, Mitchell JM, Cone EJ. Huestis MA, et al. J Anal Toxicol. 1995 Oct;19(6):443-9. doi: 10.1093/jat/19.6.443. J Anal Toxicol. 1995. PMID: 8926739 Clinical Trial.

6

Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry.

Huestis MA, Oyler JM, Cone EJ, Wstadik AT, Schoendorfer D, Joseph RE Jr. Huestis MA, et al. J Chromatogr B Biomed Sci Appl. 1999 Oct 15;733(1-2):247-64. doi: 10.1016/s0378-4347(99)00246-7. J Chromatogr B Biomed Sci Appl. 1999. PMID: 10572984 Review.

7

Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.

Huestis MA, Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Frank RA. Huestis MA, et al. Arch Gen Psychiatry. 2001 Apr;58(4):322-8. doi: 10.1001/archpsyc.58.4.322. Arch Gen Psychiatry. 2001. PMID: 11296091 Clinical Trial.

8

Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration.

Kim I, Barnes AJ, Oyler JM, Schepers R, Joseph RE Jr, Cone EJ, Lafko D, Moolchan ET, Huestis MA. Kim I, et al. Among authors: huestis ma. Clin Chem. 2002 Sep;48(9):1486-96. Clin Chem. 2002. PMID: 12194925 Clinical Trial.

9

Duration of detectable methamphetamine and amphetamine excretion in urine after controlled oral administration of methamphetamine to humans.

Oyler JM, Cone EJ, Joseph RE Jr, Moolchan ET, Huestis MA. Oyler JM, et al. Among authors: huestis ma. Clin Chem. 2002 Oct;48(10):1703-14. Clin Chem. 2002. PMID: 12324487

10

Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers.

Schepers RJ, Oyler JM, Joseph RE Jr, Cone EJ, Moolchan ET, Huestis MA. Schepers RJ, et al. Among authors: huestis ma. Clin Chem. 2003 Jan;49(1):121-32. doi: 10.1373/49.1.121. Clin Chem. 2003. PMID: 12507968 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

537 results

Search Page

Filters